Development
Zeo ScientifiX, Inc.
ZEOX
$1.96
-$0.01-0.51%
OTC PK
| 10/31/2023 | 07/31/2023 | 04/30/2023 | 01/31/2023 | 10/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 1.42M | 1.22M | 845.50K | 1.07M | 1.44M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.42M | 1.22M | 845.50K | 1.07M | 1.44M |
| Cost of Revenue | 132.90K | 162.30K | 108.10K | 104.30K | 269.20K |
| Gross Profit | 1.29M | 1.06M | 737.40K | 965.90K | 1.17M |
| SG&A Expenses | 2.41M | 2.50M | 2.65M | 3.14M | 4.36M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.54M | 2.67M | 2.76M | 3.25M | 4.62M |
| Operating Income | -1.12M | -1.45M | -1.91M | -2.18M | -3.18M |
| Income Before Tax | -1.09M | -1.62M | -1.99M | -2.29M | -3.15M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.09M | -1.62M | -1.99M | -2.29M | -3.15M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.09M | -1.62M | -1.99M | -2.29M | -3.02M |
| EBIT | -1.12M | -1.45M | -1.91M | -2.18M | -3.18M |
| EBITDA | -1.11M | -1.29M | -1.76M | -2.02M | -2.92M |
| EPS Basic | -0.16 | -0.23 | -0.27 | -0.33 | -0.47 |
| Normalized Basic EPS | -0.11 | -0.14 | -0.17 | -0.20 | -0.29 |
| EPS Diluted | -0.16 | -0.23 | -0.27 | -0.33 | -0.47 |
| Normalized Diluted EPS | -0.11 | -0.14 | -0.17 | -0.20 | -0.29 |
| Average Basic Shares Outstanding | 7.03M | 7.10M | 7.27M | 7.01M | 5.69M |
| Average Diluted Shares Outstanding | 7.03M | 7.10M | 7.27M | 7.01M | 5.69M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |